Brighton Securities’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$270K Sell
2,102
-46
-2% -$5.38K 0.12% 32
2026
Q1
$258K Sell
2,148
-550
-20% -$63.5K 0.12% 35
2025
Q4
$284K Sell
2,698
-328
-11% -$30.8K 0.14% 30
2025
Q3
$254K Sell
3,026
-209
-6% -$17.2K 0.13% 36
2025
Q2
$256K Sell
3,235
-1,674
-34% -$133K 0.14% 56
2025
Q1
$441K Buy
4,909
+751
+18% +$70.1K 0.21% 30
2024
Q4
$414K Buy
+4,158
New +$429K 0.2% 35

Other funds holding MRK

Brighton Securities's MRK Position: Q2 2026 in Review

Brighton Securities reduced its Merck (MRK) stake by 2.1% in Q2 2026, selling an estimated $5.38K and leaving 2,102 shares worth $270K. The position accounts for 0.12% of the portfolio, ranked #32.

Brighton Securities first reported a position in MRK in Q4 2024 and has held it in 7 quarters since. The position peaked at $441K in Q1 2025. 3,819 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Brighton Securities held 2,102 shares of Merck worth $270K as of Q2 2026.
  • Brighton Securities sold 46 Merck shares in Q2 2026, an estimated $5.38K.
  • Merck made up 0.12% of Brighton Securities's portfolio in Q2 2026, its #32 holding.
  • Brighton Securities first reported a position in Merck in Q4 2024 and has held it in 7 quarters since.
  • Brighton Securities's Merck position peaked at $441K in Q1 2025.
  • 3,819 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Brighton Securities's 13F filing for Q2 2026, filed 7 Jul 2026.